Press release

  • 2024-01-31

    ImmuneBiotech Medical Sweden AB strengthens its Board of Directors by welcoming life science professional Sara Malcus as Chairman of the Board and Svante Hjertén as Board Member
  • 2023-05-11

    ImmuneBiotech Medical Sweden AB announces the appointment of international microbiome expert Kristin Wannerberger to board of directors
  • 2021-01-20

    ImmuneBiotech closes fully subscribed new share issue with funding from recognized investors and existing shareholders
  • 2020-09-22

    ImmuneBiotech: Patent granted for GutMagnific® in the United States
  • 2020-06-10

    ImmuneBiotech: starts clinical trial of GutMagnific® in ME/CFS in collaboration with Stora Sköndal ME clinic
  • 2019-10-16

    ImmuneBiotech: market launch of first product GutMagnific
  • 2019-05-07

    ImmuneBiotech: Winner of H2020 “SME Instrument” Phase 1
  • 2019-01-24

    ImmuneBiotech closes new share issue with funding from recognized international investors and business angels


Press contact

For media inquiries, please write to

ImmuneBiotech AB
Scheelevägen 2, Medicon Village
223 81 Lund, Sweden
Phone: +46 46 25 25 50
GutMagnific Web Shop:

Follow us on LinkedIn for the latest updates and information.